Related references
Note: Only part of the references are listed.Randomised clinical trial: deep remission in biologic and immunomodulator naive patients with Crohn's disease - a SONIC post hoc analysis
J. -F. Colombel et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Effects of Concomitant Immunomodulator Therapy on Efficacy and Safety of Anti-Tumor Necrosis Factor Therapy for Crohn's Disease: A Meta-analysis of Placebo-controlled Trials
Jennifer L. Jones et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Risk of Lymphoma in Patients With Inflammatory Bowel Disease Treated With Azathioprine and 6-Mercaptopurine: A Meta-analysis
David S. Kotlyar et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Comparative Effectiveness of Immunosuppressants and Biologics for Inducing and Maintaining Remission in Crohn's Disease: A Network Meta-analysis
Glen S. Hazlewood et al.
GASTROENTEROLOGY (2015)
Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease
Marieke J. H. Coenen et al.
GASTROENTEROLOGY (2015)
Clinical Practice Guidelines for the Medical Management of Nonhospitalized Ulcerative Colitis: The Toronto Consensus
Brian Bressler et al.
GASTROENTEROLOGY (2015)
Clinical Impact of Concomitant Immunomodulators on Biologic Therapy: Pharmacokinetics, Immunogenicity, Efficacy and Safety
Zhenhua Xu et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Successful Mercaptopurine Usage despite Azathioprine-Induced Pancreatitis in Paediatric Crohn's Disease
Silvia Gallego-Gutierrez et al.
JOURNAL OF CROHNS & COLITIS (2015)
Oral Cancer and Oral Precancerous Lesions in Inflammatory Bowel Diseases: A Systematic Review
Konstantinos H. Katsanos et al.
JOURNAL OF CROHNS & COLITIS (2015)
Prospective population-based cohort of inflammatory bowel disease in the biologics era: Disease course and predictors of severity
Olga Niewiadomski et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2015)
Crohn's disease management after intestinal resection: a randomised trial
Peter De Cruz et al.
LANCET (2015)
Pregnancy outcomes in women with inflammatory bowel disease following exposure to thiopurines and antitumor necrosis factor drugs: A systematic review with meta-analysis
S. Mozaffari et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2015)
Risk of cervical cancer in women with autoimmune diseases, in relation with their use of immunosuppressants and screening: Population-based cohort study
Pierre-Antoine Dugue et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Long-term Efficacy and Safety of Azathioprine in Ulcerative Colitis
Ruchit Sood et al.
JOURNAL OF CROHNS & COLITIS (2015)
The Second European Evidenced-Based Consensus on Reproduction and Pregnancy in Inflammatory Bowel Disease
C. J. van der Woude et al.
JOURNAL OF CROHNS & COLITIS (2015)
Review article: why, when and how to de-escalate therapy in inflammatory bowel diseases
B. Pariente et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease: relapse and recapture rates, with predictive factors in 237 patients
N. A. Kennedy et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Placebo Response Rate in Clinical Trials of Fistulizing Crohn's Disease: Systematic Review and Meta-analysis
Alexander C. Ford et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
Increased Risk of Acute Myeloid Leukemias and Myelodysplastic Syndromes in Patients Who Received Thiopurine Treatment for Inflammatory Bowel Disease
Anthony Lopez et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
Methotrexate in Combination With Infliximab Is No More Effective Than Infliximab Alone in Patients With Crohn's Disease
Brian G. Feagan et al.
GASTROENTEROLOGY (2014)
Combination Therapy With Infliximab and Azathioprine Is Superior to Monotherapy With Either Agent in Ulcerative Colitis
Remo Panaccione et al.
GASTROENTEROLOGY (2014)
Azathioprine in Early Crohn's Disease: Time to Revisit Patient Selection and End Points for Clinical Trials and/or Azathioprine Efficacy?
Peter L. Lakatos et al.
GASTROENTEROLOGY (2014)
Long-term Combination Therapy with Infliximab Plus Azathioprine Predicts Sustained Steroid-free Clinical Benefit in Steroid-dependent Ulcerative Colitis
Alessandro Armuzzi et al.
INFLAMMATORY BOWEL DISEASES (2014)
Association Between 6-Thioguanine Nucleotides Levels and Clinical Remission in Inflammatory Disease: A Meta-analysis
Amelie Carla Moreau et al.
INFLAMMATORY BOWEL DISEASES (2014)
HLA-DQA1-HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants
Graham A. Heap et al.
NATURE GENETICS (2014)
Use of Azathioprine and the Risk of Cancer in Inflammatory Bowel Disease
Bjorn Pasternak et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2013)
Adalimumab Is More Effective Than Azathioprine and Mesalamine at Preventing Postoperative Recurrence of Crohn's Disease: A Randomized Controlled Trial
Edoardo Savarino et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Safety of Thiopurines and Anti-TNF-α Drugs During Pregnancy in Patients With Inflammatory Bowel Disease
M. J. Casanova et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Addition of an Immunomodulator to Infliximab Therapy Eliminates Antidrug Antibodies in Serum and Restores Clinical Response of Patients With Inflammatory Bowel Disease
Shomron Ben-Horin et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Penetrating or Stricturing Diseases are the Major Determinants of Time to First and Repeat Resection Surgery in Crohn's Disease
Valerie Pittet et al.
DIGESTION (2013)
Is There Still a Role for Thiopurines in Crohn's Disease?
Gerhard Rogler et al.
GASTROENTEROLOGY (2013)
Early Administration of Azathioprine vs Conventional Management of Crohn's Disease: A Randomized Controlled Trial
Jacques Cosnes et al.
GASTROENTEROLOGY (2013)
Early Azathioprine Therapy Is No More Effective Than Placebo for Newly Diagnosed Crohn's Disease
Julian Panes et al.
GASTROENTEROLOGY (2013)
Risk of Lymphoma in Patients With Ulcerative Colitis Treated With Thiopurines: A Nationwide Retrospective Cohort Study
Nabeel Khan et al.
GASTROENTEROLOGY (2013)
American Gastroenterological Association Institute Technical Review on the Use of Thiopurines, Methotrexate, and Anti-TNF-α Biologic Drugs for the Induction and Maintenance of Remission in Inflammatory Crohn's Disease
Themistocles Dassopoulos et al.
GASTROENTEROLOGY (2013)
American Gastroenterological Association Institute Guideline on the Use of Thiopurines, Methotrexate, and Anti-TNF-α Biologic Drugs for the Induction and Maintenance of Remission in Inflammatory Crohn's Disease
Jonathan P. Terdiman et al.
GASTROENTEROLOGY (2013)
Safety and Effectiveness of Long-term Allopurinol-Thiopurine Maintenance Treatment in Inflammatory Bowel Disease
Frank Hoentjen et al.
INFLAMMATORY BOWEL DISEASES (2013)
When do we dare to stop biological or immunomodulatory therapy for Crohn's disease? Results of a multidisciplinary European expert panel
Valerie Pittet et al.
JOURNAL OF CROHNS & COLITIS (2013)
The effect of allopurinol and low-dose thiopurine combination therapy on the activity of three pivotal thiopurine metabolizing enzymes: Results from a prospective pharmacological study
M. L. Seinen et al.
JOURNAL OF CROHNS & COLITIS (2013)
Review article: the benefits of pharmacogenetics for improving thiopurine therapy in inflammatory bowel disease
L. Chouchana et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Split-dose administration of thiopurine drugs: a novel and effective strategy for managing preferential 6-MMP metabolism
D. Q. Shih et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Long-term outcome of ulcerative colitis in patients who achieve clinical remission with a first course of corticosteroids
Esther Garcia-Planella et al.
DIGESTIVE AND LIVER DISEASE (2012)
The potential influence of 5-aminosalicylic acid on the induction of myelotoxicity during thiopurine therapy in inflammatory bowel disease patients
Xiang Gao et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2012)
Mucosal healing in inflammatory bowel diseases: a systematic review
Markus F. Neurath et al.
GUT (2012)
Use of thiopurines in the treatment of inflammatory bowel disease is associated with an increased risk of non-melanoma skin cancer in an at-risk population: A cohort study
Mashiko Setshedi et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2012)
Should Thiopurine Methyltransferase Genotypes and Phenotypes be Measured Before Thiopurine Therapy in Patients With Inflammatory Bowel Disease?
Zhang Fangbin et al.
THERAPEUTIC DRUG MONITORING (2012)
Randomised clinical trial: certolizumab pegol for fistulas in Crohn's disease - subgroup results from a placebo-controlled study
S. Schreiber et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
A Systematic Review of Factors That Contribute to Hepatosplenic T-Cell Lymphoma in Patients With Inflammatory Bowel Disease
David S. Kotlyar et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
Pharmacokinetic Properties of Infliximab in Children and Adults with Crohn's Disease: A Retrospective Analysis of Data from 2 Phase III Clinical Trials
Adedigbo A. Fasanmade et al.
CLINICAL THERAPEUTICS (2011)
Increased Risk for Nonmelanoma Skin Cancers in Patients Who Receive Thiopurines for Inflammatory Bowel Disease
Laurent Peyrin-Biroulet et al.
GASTROENTEROLOGY (2011)
Incidence of Nodular Regenerative Hyperplasia in Inflammatory Bowel Disease Patients Treated with Azathioprine
Philippe Seksik et al.
INFLAMMATORY BOWEL DISEASES (2011)
Long-term follow-up of babies exposed to azathioprine in utero and via breastfeeding
Sieglinde Angelberger et al.
JOURNAL OF CROHNS & COLITIS (2011)
Association of Crohn's Disease, Thiopurines, and Primary Epstein-Barr Virus Infection with Hemophagocytic Lymphohistiocytosis
Vincent F. Biank et al.
JOURNAL OF PEDIATRICS (2011)
Predictors of Infliximab Failure After Azathioprine Withdrawal in Crohn's Disease Treated With Combination Therapy
Abderrahim Oussalah et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Influence of 5-aminosalicylic acid on 6-thioguanosine phosphate metabolite levels: a prospective study in patients under steady thiopurine therapy
P. de Graaf et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Increased Risk for Non-Melanoma Skin Cancer in Patients With Inflammatory Bowel Disease
Millie D. Long et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2010)
Usefulness of co-treatment with immunomodulators in patients with inflammatory bowel disease treated with scheduled infliximab maintenance therapy
Harry Sokol et al.
GUT (2010)
Efficacy and Safety of Certolizumab Pegol Induction Therapy in an Unselected Crohn's Disease Population: Results of the FACTS Survey
Alain M. Schoepfer et al.
INFLAMMATORY BOWEL DISEASES (2010)
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations
Gert Van Assche et al.
JOURNAL OF CROHNS & COLITIS (2010)
Clinical implications of mucosal healing for the management of IBD
Guillaume Pineton de Chambrun et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2010)
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease.
Jean Frederic Colombel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Thiopurine S-methyltransferase polymorphisms and thiopurine toxicity in treatment of inflammatory bowel disease
Xian-Wen Dong et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Systematic review: does concurrent therapy with 5-ASA and immunomodulators in inflammatory bowel disease improve outcomes?
J. M. Andrews et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Clinical trial: benefits and risks of immunomodulators and maintenance infliximab for IBD-subgroup analyses across four randomized trials
G. R. Lichtenstein et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Maintenance Treatment With Azathioprine in Ulcerative Colitis: Outcome and Predictive Factors After Drug Withdrawal
Andrea Cassinotti et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Early Pregnancy Azathioprine Use and Pregnancy Outcomes
Brian J. Cleary et al.
BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY (2009)
Azathioprine Withdrawal in Patients With Crohn's Disease Maintained on Prolonged Remission: A High Risk of Relapse
Xavier Treton et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Risk of Lymphoma Associated With Combination Anti-Tumor Necrosis Factor and Immunomodulator Therapy for the Treatment of Crohn's Disease: A Meta-Analysis
Corey A. Siegel et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Azathioprine Is Superior to Budesonide in Achieving and Maintaining Mucosal Healing and Histologic Remission in Steroid-dependent Crohn's Disease
Gerassimos J. Mantzaris et al.
INFLAMMATORY BOWEL DISEASES (2009)
Fatal Epstein-Barr Virus Primo Infection in a 25-Year-Old Man Treated with Azathioprine for Crohn's Disease
Y. N'Guyen et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease
J. F. Rahier et al.
JOURNAL OF CROHNS & COLITIS (2009)
Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study
Laurent Beaugerie et al.
LANCET (2009)
Azathioprine treatment during lactation
L. A. Christensen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn's disease: A controlled randomized trial
Geert R. D'Haens et al.
GASTROENTEROLOGY (2008)
Withdrawal of immunosuppression in Crohn's disease treated with scheduled infliximab maintenance: a Randomized trial
Gert Van Assche et al.
GASTROENTEROLOGY (2008)
GRADE:: an emerging consensus on rating quality of evidence and strength of recommendations
Gordon H. Guyatt et al.
BRITISH MEDICAL JOURNAL (2008)
Effectiveness of concomitant immunosuppressive therapy in suppressing the formation of antibodies to infliximab in Crohn's disease
Severine Vermeire et al.
GUT (2007)
Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial
W. J. Sandborn et al.
GUT (2007)
Therapeutic drug use in women with crohn's disease and birth outcomes:: A danish nationwide cohort study
Bente Norgard et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Assessment of thiopurine methyltransferase enzyme activity is superior to genotype in predicting myelosuppression following azathioprine therapy in patients with inflammatory bowel disease
J. W. Winter et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Effect of allopurinol on clinical outcomes in inflammatory bowel disease nonresponders to azathioprine or 6-mercaptopurine
Miles P. Sparrow et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine
Karin Dilger et al.
THERAPEUTIC DRUG MONITORING (2007)
Azathioprine use during pregnancy: Unexpected intrauterine exposure to metabolites
NKH de Boer et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Association of 6-thioguanine nucleotide levels and inflammatory bowel disease activity: A meta-analysis
MT Osterman et al.
GASTROENTEROLOGY (2006)
Infliximab plus azathioprine for steroid-dependent Crohn's disease patients:: A randomized placebo-controlled trial
M Lémann et al.
GASTROENTEROLOGY (2006)
Review article: thiopurines in inflammatory bowel disease
L. J. J. Derijks et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis
S Ardizzone et al.
GUT (2006)
Effects of perioperative antiinflammatory and immunomodulating therapy on surgical wound healing
AJ Busti et al.
PHARMACOTHERAPY (2005)
A cost-effectiveness analysis of alternative disease management strategies in patients with Crohn's disease treated with azathioprine or 6-mercaptopurine
MC Dubinsky et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine
A Kandiel et al.
GUT (2005)
Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease
RB Gearry et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2005)
A randomized, douuble-blind, controlled withdrawal trial in Crohn's disease patients in long-term remission on azathioprine
M Lémann et al.
GASTROENTEROLOGY (2005)
Selective inhibition of inflammatory gene expression in activated T lymphocytes: A mechanism of immune suppression by thiopurines
CW Thomas et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy
JF Colombel et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
Guidelines for immunizations in patients with inflammatory bowel disease
BE Sands et al.
INFLAMMATORY BOWEL DISEASES (2004)
Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: A 2-year trial
SB Hanauer et al.
GASTROENTEROLOGY (2004)
Multivariate analysis suggests improved perioperative outcome in Crohn's disease patients receiving immunomodulator therapy after segmental resection and/or strictureplasty
GS Tay et al.
SURGERY (2003)
Corticosteroids and immunomodulators: Postoperative infectious complication risk in inflammatory bowel disease patients
FN Aberra et al.
GASTROENTEROLOGY (2003)
Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease
F Baert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Azathioprine or methotrexate in the treatment of patients with steroid-dependent or steroid-resistant ulcerative colitis: results of an open-label study on efficacy and tolerability in inducing and maintaining remission
OA Paoluzi et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)
Thiopurine methyltransferase activity and the use of azathioprine in inflammatory bowel disease
A Ansari et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)
The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review
AG Fraser et al.
GUT (2002)
6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease
MC Dubinsky et al.
GASTROENTEROLOGY (2002)
Azathioprine intolerance in patients with IBD may be imidazole-related and is independent of TPMT activity
DPB McGovern et al.
GASTROENTEROLOGY (2002)
Review article: the treatment of inflammatory bowel disease with 6-mercaptopurine or azathioprine
OH Nielsen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2001)
The natural history of corticosteroid therapy for inflammatory bowel disease: A population-based study
WA Faubion et al.
GASTROENTEROLOGY (2001)
Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery
DM Grennan et al.
ANNALS OF THE RHEUMATIC DISEASES (2001)
Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease
MC Dubinsky et al.
GASTROENTEROLOGY (2000)
Share Paper
